Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Nanjing Liming Biological Products Co., Ltd. is a leading Chinese biotechnology company established in 2001, specializing in the research, development, and manufacturing of rapid in vitro diagnostic (IVD) tests. The company is a major provider of point-of-care testing (POCT) solutions, with a core focus on infectious diseases such as sexually transmitted diseases (STDs), respiratory infections including COVID-19, and gastrointestinal disorders. Marketed under the StrongStep brand, their product portfolio includes high-sensitivity tests for pathogens like Chlamydia, Gonorrhea, and Syphilis, as well as markers for fertility and oncology screening. Liming Bio utilizes advanced technologies including colored latex chromatography and molecular detection (PCR) to deliver accurate, cost-effective results in minutes. The company operates a 3,000-square-meter manufacturing facility in Nanjing and holds international certifications such as CE, ISO 13485, and CFDA approval, serving a global market across human and veterinary diagnostics.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Nanjing Liming Biological Preparations.